Impact on quality of life from multimodality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multimodality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial)
Blackhall, Fiona H
AffiliationChristie Patient Centred Research, The Christie NHS Foundation Trust, Manchester, UK
MetadataShow full item record
AbstractIntroduction: Optimal treatment for 'potentially resectable' stage III-N2 non-small cell lung cancer (NSCLC) requires multimodality treatment: local treatment (surgery or radiotherapy) and systemic anticancer therapy. There is no clear evidence of superiority for survival between the two approaches and little research has explored quality of life (QOL). This study will inform the design of a phase III randomised trial of surgery versus no surgery as part of multimodality treatment for stage III-N2 NSCLC with QOL as a primary outcome. Methods and analysis: Patient participants will be randomised to receive multimodality treatment (1) with surgery OR (2) without surgery. The Quintet Recruitment Intervention will be used to maximise recruitment. Eligible patients will have 'potentially resectable' N2 NSCLC and have received a multidisciplinary team recommendation for multimodality treatment. Sixty-six patients and their carers will be recruited from 8 UK centres. Patient/carer QOL questionnaires will be administered at baseline, weeks 6, 9, 12 and month 6. Semistructured interviews will be conducted. Quantitative data will be analysed descriptively and qualitative data will be analysed using framework analysis.
CitationTaylor S, Yorke J, Tsim S, Navani N, Baldwin D, Woolhouse I, et al. Impact on quality of life from multimodality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multimodality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial). BMJ Open Resp Res. 2021 Jul;8(1):e000846.
JournalBMJ Open Respiratory Research
- Stage III Non-small Cell Lung Cancer: A UK National Survey of Practice.
- Authors: Evison M, Edwards J, McDonald F, Popat S
- Issue date: 2020 Aug
- Study protocol for VIdeo assisted thoracoscopic lobectomy versus conventional Open LobEcTomy for lung cancer, a UK multicentre randomised controlled trial with an internal pilot (the VIOLET study).
- Authors: Lim E, Batchelor T, Shackcloth M, Dunning J, McGonigle N, Brush T, Dabner L, Harris R, Mckeon HE, Paramasivan S, Elliott D, Stokes EA, Wordsworth S, Blazeby J, Rogers CA, VIOLET Trialists.
- Issue date: 2019 Oct 14
- Surgery as a Component of Multimodality Care for Known Stage IIIA-N2 Non-small Cell Lung Cancer.
- Authors: Bograd AJ, Vallières E
- Issue date: 2020 Jun
- Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
- Authors: Zhu J, Li R, Tiselius E, Roudi R, Teghararian O, Suo C, Song H
- Issue date: 2017 Dec 16
- Advances in the use of surgery and multimodality treatment for N2 non-small cell lung cancer.
- Authors: Van Schil PE, Yogeswaran K, Hendriks JM, Lauwers P, Faivre-Finn C
- Issue date: 2017 Jun